Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1

Summary The success of current antiviral treatment for hepatitis C virus (HCV) recurrence in liver transplant (LT) recipients remains limited. We aimed at evaluating the value of IL28B genotype and early viral kinetics to predict response to standard treatment in the transplant setting. We retrospec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of viral hepatitis 2014-10, Vol.21 (10), p.e118-e128
Hauptverfasser:	Campos-Varela, I., Esteban, J. I., Bes, M., Caralt, M., Allende, H., Rodríguez-Frías, F., Salcedo, M. T., Sauleda, S., Charco, R., Guardia, J., Esteban, R., Castells, L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Age Factors Aged Aged, 80 and over Antiviral Agents - therapeutic use antiviral treatment Female Genotype Hepacivirus - genetics Hepacivirus - growth & development hepatitis C virus Hepatitis C, Chronic - diagnosis Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Humans Interferons Interleukins - genetics liver transplant Liver Transplantation Male Middle Aged Prognosis prognostic analysis Recurrence Retrospective Studies risk stratification sustained virological response Transplant Recipients Treatment Outcome Viral Load Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!